NEW YORK, Feb. 7 (GenomeWeb News) - The National Cancer Institute has awarded Insightful two contracts worth a total of $185,807 to develop advanced bioinformatics software to analyze and evaluate proteomic cellular signatures in cancer prevention research, Insightful said today.
The software will use Insightful's S-Plus 7 and S+ArrayAnalyzer products, the company said.
The initial contracts call for solutions to the "challenges of preprocessing mass spectrometry data," Insightful said. The company is planning to develop software that includes calibration, denoising, baseline detrending, intensity normalization, peak detection, alignment, feature selection and extraction, as well as graphics.
Insightful said the funding will be recorded in the company's financial statements as a reduction to research and development expense.